Home/Pipeline/Angong Niuhuang Wan

Angong Niuhuang Wan

Stroke, Cerebral Ischemia

Phase IV / Post-MarketingActiveN/A (Real-World Evidence Studies)

Key Facts

Indication
Stroke, Cerebral Ischemia
Phase
Phase IV / Post-Marketing
Status
Active
Company

About Tong Ren Tang

Tong Ren Tang's mission is to preserve, innovate, and globalize the science and practice of Traditional Chinese Medicine. Its key achievement is maintaining an unbroken 354-year legacy of quality and trust, successfully transitioning into a $38.66 billion publicly listed entity while safeguarding a proprietary library of classical formulations. The company's strategy is built on vertical integration—from sustainable herb cultivation and advanced manufacturing to a controlled global retail footprint—leveraging its unparalleled brand recognition to capture growth in wellness, chronic disease management, and international markets.

View full company profile